Promoting Buprenorphine-Naloxone management in primary care settings through provider education
Title
Promoting Buprenorphine-Naloxone management in primary care settings through provider education
Creator
Nogalski, Jennifer
Description
Nogalski, Jennifer
The opioid epidemic was declared in October 2017 in the United States (Center for Medicare & Medicaid Services [CMS], 2021), with the literature demonstrating buprenorphine-naloxone as a key treatment for opioid use disorder. Despite the evidence, few Primary Care Providers (PCPs) had the ability or willingness to prescribe buprenorphine-naloxone. Purpose: This study aimed to assess whether an educational intervention changed the PCPs willingness to prescribe buprenorphine-naloxone in their practice. Methods: This project was a quantitative, prospective, correlative design as it sought to survey PCPs through descriptive data in a 5-point Likert Scale post-education survey. The educational intervention was provided to PCPs in a large organization within Washington County, Wisconsin. The post-education survey assessed for the PCPs willingness to prescribe buprenorphine-naloxone and whether they would seek further education. Results: The results suggests that a strong positive association between education and willingness to prescribe, (rho =1, N = 6), as well as, a potential strong association between the educational intervention and intent to seek out further education (rho = .74, N = 6, p= .08). Discussion: The results demonstrated a likelihood to prescribe and seek out further education in a small sample size. This study is applicable to the practice setting to advance provider prescribing practices, healthcare policy for adequate care of opioid use disorder patients and clinical guideline development. Further research should investigate larger populations and the educational intervention.
The opioid epidemic was declared in October 2017 in the United States (Center for Medicare & Medicaid Services [CMS], 2021), with the literature demonstrating buprenorphine-naloxone as a key treatment for opioid use disorder. Despite the evidence, few Primary Care Providers (PCPs) had the ability or willingness to prescribe buprenorphine-naloxone. Purpose: This study aimed to assess whether an educational intervention changed the PCPs willingness to prescribe buprenorphine-naloxone in their practice. Methods: This project was a quantitative, prospective, correlative design as it sought to survey PCPs through descriptive data in a 5-point Likert Scale post-education survey. The educational intervention was provided to PCPs in a large organization within Washington County, Wisconsin. The post-education survey assessed for the PCPs willingness to prescribe buprenorphine-naloxone and whether they would seek further education. Results: The results suggests that a strong positive association between education and willingness to prescribe, (rho =1, N = 6), as well as, a potential strong association between the educational intervention and intent to seek out further education (rho = .74, N = 6, p= .08). Discussion: The results demonstrated a likelihood to prescribe and seek out further education in a small sample size. This study is applicable to the practice setting to advance provider prescribing practices, healthcare policy for adequate care of opioid use disorder patients and clinical guideline development. Further research should investigate larger populations and the educational intervention.
Date
2024
Publisher
Alverno College
Extent
139 pages
Language
English
Format
PDF
Type
Text
DNP Project
Subject
Opioid abuse
Physicians--Education
Opioid epidemic
Buprenorphine-naloxone
Provider education
Opioid use disorder
Rights
These materials may be used by individuals and libraries for personal use, research, teaching (including distribution to classes), or for any fair use as defined by U.S. Copyright Law.
Collection
Citation
Nogalski, Jennifer, “Promoting Buprenorphine-Naloxone management in primary care settings through provider education,” Alverno College Library Digital Commons, accessed June 14, 2026, https://alverno.omeka.net/items/show/922.